2012. Roflumilast – a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD. Swiss Medical Weekly. 142, 2930 (Jul. 2012), w13628. DOI:https://doi.org/10.4414/smw.2012.13628.